Pressroom

See all trending topics »Trending Topics

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator »

First Anti-PD-1 Drug Approved by FDA for Patients with Advanced Melanoma

The first in a new class of immunotherapy drugs was granted FDA approval on September 4, 2014. MSK physicians played a major role in the clinical trials that led to its approval and are continuing to conduct trials using the therapy in melanoma and other cancers.

Friday, September 5, 2014
Memorial Sloan Kettering Study Finds Robotic Surgery No Better Than Open Procedure for Bladder Cancer

Physicians at Memorial Sloan Kettering have found that robotic surgery to remove a cancerous bladder did not reduce the risk of complications as compared with traditional open surgery. Findings were published this week in the New England Journal of Medicine. The study was conducted at MSK with surgeons experienced in both procedures and raises questions about the cost effectiveness of robotic surgery. For more information and to set up interviews with Dr. Bernard Bochner or Dr. Vincent Laudone, please contact Emily O’Donnell at odonnele@mskcc.org.

Thursday, July 24, 2014
Memorial Sloan Kettering Ranks First in the Nation for Cancer Care

Memorial Sloan Kettering is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the revered list 25 years ago, MSK has held either the first or second spot each year.

Tuesday, July 15, 2014

See all press releases »Press Releases

Hartford HealthCare Cancer Institute Officially Certified as the First Member of the Memorial Sloan Kettering Cancer Alliance

The Hartford HealthCare Cancer Institute has been formally certified as the charter member of the Memorial Sloan Kettering Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings.

Tuesday, September 16, 2014
Pictured: Yu Chen
The Newest Precision Medicine Tool: Prostate Cancer Organoids

Research led by investigators at Memorial Sloan Kettering has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory.

Thursday, September 4, 2014
MSK and Pereira & O’Dell New York Launch Campaign to Announce MSK’s New Creative Platform: More Science. Less Fear.

MSK introduced its first new creative campaign in nearly two decades. The creative platform and campaign elements were developed and produced by MSK’s creative agency of record, Pereira & O’Dell New York.

Tuesday, September 2, 2014

See all story starters »Story Starters

Need story ideas? Use our evergreen story suggestions to generate new content or complement something you're already working on.

See all blog posts »On Our Blog

MSK and Hartford leadership holding certificate
Announcement
MSK Cancer Alliance Grants Hartford HealthCare Cancer Institute Certified Member Status

The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.

Thursday, September 18, 2014
Pictured: Experimental Brain Tumor
In the Lab
Genetic “Kill Switch” Could Make Cell Therapies Safer

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Thursday, September 18, 2014
Pictured: David Abramson
In the Clinic
Retinoblastoma Program Marks 100 Years

Retinoblastoma expert David Abramson discusses how treatments and survival rates have greatly improved for this rare pediatric eye cancer.

Monday, September 15, 2014

MSK News Highlights

Watch highlights including news coverage of recent scientific and clinical developments at Memorial Sloan Kettering, our physicians and scientists in the national spotlight, and our amazing staff and programs.

Watch Video »

See all media coverage »Media Coverage

Gene Mutation Discovered In Breast Cancer Research

Clinical geneticist Kenneth Offit discussed new findings about a gene called PALB2 that is linked to breast cancer.

Friday, August 8, 2014
Early Stem Cell Transplant Vital in 'Bubble Boy' Disease

Pediatric oncologist Richard O’Reilly discussed a study he led that confirms that transplantation for severe combined immunodeficiency works well in very young children.

Thursday, July 31, 2014
Can Doctors Teach the Body to Cure Cancer?

Medical oncologist Jedd Wolchok discussed immunotherapies that can empower a patient’s immune system to fight cancer.

Monday, July 28, 2014

For Journalists

Contact Media Staff

Jeanne D'Agostino
Media Relations Manager
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Andrea Baird
Media Associate

For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.

After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

#1 in Cancer Care

MSK Named #1 by U.S. News

News & World Report named Memorial Sloan Kettering the top hospital for cancer care in the nation. We're honored, and patient care will always be our top priority.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to Our
E-Newsletter

Our e-mail newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign Up

Read recent issues »